FDA Inspection
Bay Area Tumor Institute IRBBay Area Tumor Institute IRB – FDA Inspection, Dec 14, 2023
Record Details
This FDA Inspection record concerns Bay Area Tumor Institute IRB, with an inspection on December 14, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 929e4975-846a-4c30-82c1-3ba56f7ff8a6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1226797
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.108(b)(2)Prompt reporting of noncompliance
- 21 CFR 56.108(b)(3)Reporting of suspension/termination
- 21 CFR 56.108(a)(1)Reporting findings and actions to investigator/institution
- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.108(b)(2)Prompt reporting of noncompliance
- 21 CFR 56.108(b)(3)Reporting of suspension/termination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bay Area Tumor Institute IRB
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 8, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 31, 2011 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Bay Area Tumor Institute IRB
- FDA Inspection 1010387 - 2017-02-08
- FDA Inspection 717551 - 2011-03-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.